The gene editing technologies market is driven by technological advancements enhancing precision, expanding applications in ...

For CPG brands already navigating evolving standards around transparency, sustainability and ingredient innovation, gene ...

The gene editing market is experiencing significant growth, with a projected annual growth rate (CAGR) of 16-18% in the coming years. This expansion is fueled by breakthroughs in gene-editing ...

If approved, Regeneron and Tessera's TSRA-196 could become the first curative therapy to reach patients with AATD, who have ...

A Japanese government expert panel agreed Thursday to legally ban and penalize research or medical practices that genetically ...

The MarketWatch News Department was not involved in the creation of this content.-- Kytopen continues expanding its partnership footprint in Europe through a new agreement with TQ ...

KAIST researchers have developed a method that attaches DNA fragments to mRNA to slow the onset of protein production, ...

Xmoor expects to gain from direct collaboration with UCL’s translational researchers, enabling it to take part in technological innovation.

For the scientific enterprise, 2025 was marked by setbacks and challenges. But scientists are no strangers to adversity—the ability to overcome obstacles is built into our training. In turn, research ...

Bristol and London, UK, 2 December 2025 - eXmoor Pharma, the UK’s only fully integrated cell and gene therapy CDMO with embedded consultancy expertise, and the Translational Research Office (TRO) at ...

A new FDA pathway could speed bespoke gene therapies, but key questions over scope and commercial viability remain.

BALI, INDONESIA – Media OutReach Newswire – 3 December 2025 – The winners of the 2025 Asia Corporate Excellence & ...